Education
About Us
Working with TipRanks
Follow Us
BioMarin Pharmaceutical (BMRN)
NASDAQ:BMRN
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.85B | $ 2.42B | $ 2.10B | $ 1.85B | $ 1.86B |
| Gross Profit | $ 2.27B | $ 1.89B | $ 1.59B | $ 1.38B | $ 1.34B |
| Operating Income | $ 484.21M | $ 185.77M | $ 160.97M | $ -82.34M | $ -43.44M |
| EBITDA | $ 650.53M | $ 306.77M | $ 265.36M | $ 47.43M | $ 83.66M |
| Net Income | $ 426.86M | $ 167.65M | $ 141.56M | $ -64.08M | $ 854.03M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.14B | $ 1.07B | $ 1.29B | $ 1.01B | $ 1.07B |
| Total Assets | $ 6.99B | $ 6.84B | $ 6.38B | $ 6.00B | $ 5.85B |
| Total Debt | $ 649.47M | $ 1.10B | $ 1.09B | $ 1.09B | $ 1.09B |
| Net Debt | $ -293.38M | $ 340.62M | $ 368.86M | $ 502.26M | $ 437.74M |
| Total Liabilities | $ 1.33B | $ 1.89B | $ 1.77B | $ 1.74B | $ 1.74B |
| Stockholders' Equity | $ 5.66B | $ 4.95B | $ 4.60B | $ 4.27B | $ 4.11B |
| Cash Flow | |||||
| Free Cash Flow | $ 475.42M | $ 62.57M | $ 54.94M | $ 185.31M | $ -52.15M |
| Operating Cash Flow | $ 572.84M | $ 159.26M | $ 175.90M | $ 304.54M | $ 85.36M |
| Investing Cash Flow | $ 136.49M | $ -111.24M | $ -20.03M | $ -366.31M | $ -53.62M |
| Financing Cash Flow | $ -526.45M | $ -18.73M | $ -18.65M | $ -48.00K | $ 181.12M |